GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (HKSE:01066) » Definitions » 5-Year Yield-on-Cost %

Shandong Weigao Group Medical Polymer Co (HKSE:01066) 5-Year Yield-on-Cost % : 5.83 (As of Apr. 26, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co 5-Year Yield-on-Cost %?

Shandong Weigao Group Medical Polymer Co's yield on cost for the quarter that ended in Jun. 2023 was 5.83.


The historical rank and industry rank for Shandong Weigao Group Medical Polymer Co's 5-Year Yield-on-Cost % or its related term are showing as below:

HKSE:01066' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.04   Med: 2.54   Max: 6.64
Current: 5.83


During the past 13 years, Shandong Weigao Group Medical Polymer Co's highest Yield on Cost was 6.64. The lowest was 1.04. And the median was 2.54.


HKSE:01066's 5-Year Yield-on-Cost % is ranked better than
81.99% of 311 companies
in the Medical Devices & Instruments industry
Industry Median: 2.22 vs HKSE:01066: 5.83

Competitive Comparison of Shandong Weigao Group Medical Polymer Co's 5-Year Yield-on-Cost %

For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Weigao Group Medical Polymer Co's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's 5-Year Yield-on-Cost % falls into.



Shandong Weigao Group Medical Polymer Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Shandong Weigao Group Medical Polymer Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Shandong Weigao Group Medical Polymer Co  (HKSE:01066) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Shandong Weigao Group Medical Polymer Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Weigao Group Medical Polymer Co (HKSE:01066) Business Description

Traded in Other Exchanges
Address
No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Headlines

No Headlines